Aarti Drugs Stock Price - ₹396.35 | Healthcare | askfuzz

Sign in to fuzzto save your conversations, follow your research and come back anytime.

‌

‌
‌

‌
‌
‌

‌
‌
‌
‌
‌
‌

Aarti Drugs Stock Price - ₹396.35 | Healthcare | askfuzz

Quarterly Results

₹Cr

Metric (₹ crore)	Q1 FY16	Q2 FY16	Q3 FY16	Q4 FY16	Q1 FY17	Q2 FY17	Q3 FY17	Q4 FY17	Q1 FY18	Q2 FY18	Q3 FY18	Q4 FY18	Q1 FY19	Q2 FY19	Q3 FY19	Q4 FY19	Q1 FY20	Q2 FY20	Q3 FY20	Q4 FY20	Q1 FY21	Q2 FY21	Q3 FY21	Q4 FY21	Q1 FY22	Q2 FY22	Q3 FY22	Q4 FY22	Q1 FY23	Q2 FY23	Q3 FY23	Q4 FY23	Q1 FY24	Q2 FY24	Q3 FY24	Q4 FY24	Q1 FY25	Q2 FY25	Q3 FY25	Q4 FY25	Q1 FY26	Q2 FY26	Q3 FY26	Q4 FY26	Q1 FY27
Sales	283.73	272.84	268.67	314.61	291.5	315.12	289.66	301.08	258.26	319.27	335.41	330.69	374.29	347.41	380.11	459.14	405.43	477.5	473.51	449.64	544.67	578.11	530.25	501.75	579.95	579.62	634.8	694.27	621.96	687.72	663.96	742.41	661.11	641.54	605.94	619.99	555.34	598.33	556.6	676.76	590.51	652.79	601.71	720.3	702.78
Expenses	239.51	230.28	225.52	268.86	243.75	264.56	247.41	252.56	222.86	266.72	281.48	274.08	321.68	300.42	328.25	403.24	350.72	409.19	406.02	378.33	410.7	461.67	424.49	420.82	500.26	505.88	544.8	608.27	554.82	613.45	593.31	648.87	577.04	565.1	535.8	534.18	490.38	531.28	494.87	583.43	516.43	568.51	546.68	624.5	604.58
EBITDA	44.22	42.56	43.15	45.75	47.75	50.56	42.25	48.52	35.4	52.55	53.93	56.61	52.61	46.99	51.86	55.9	54.71	68.31	67.49	71.31	133.97	116.44	105.76	80.93	79.69	73.74	90	86	67.14	74.27	70.65	93.54	84.07	76.44	70.14	85.81	64.96	67.05	61.73	93.33	74.08	84.28	55.03	95.8	98.2
Depreciation	8.89	9.07	9.22	9.35	9.62	9.74	9.94	9.16	9.81	10.06	9.97	10.23	10.4	10.63	10.72	10.81	11.81	12.09	12.36	12.49	12.38	12.56	12.65	12.28	12.42	12.48	12.6	12.55	12.54	12.66	12.62	12.5	12.6	12.61	12.66	13.58	13.38	13.72	13.8	14.88	14.72	16.26	17.95	18.04	18.46
EBIT	35.33	33.49	33.93	36.4	38.13	40.82	32.31	39.36	25.59	42.49	43.96	46.38	42.21	36.36	41.14	45.09	42.9	56.22	55.13	58.82	121.59	103.88	93.11	68.65	67.27	61.26	77.4	73.45	54.6	61.61	58.03	81.04	71.47	63.83	57.48	72.23	51.58	53.33	47.93	78.45	59.36	68.02	37.08	77.76	79.74
Interest	10.44	10.78	11.15	11.51	9.96	8.78	9.09	8.58	8.94	8.03	9.06	8.93	9.41	9.73	10.48	10.34	9.33	8.54	8.39	7.47	6.57	7.05	4.97	4.37	4.21	5.26	5.37	5.91	6.83	8.47	9.36	8.63	8.54	8.25	7.6	9.13	8.71	8.93	9.07	9.16	8.56	7.7	9.29	8.16	9.22
Profit Before Tax	24.89	22.71	22.78	24.89	28.17	32.04	23.22	30.78	16.65	34.46	34.9	37.45	32.8	26.63	30.66	34.75	33.57	47.68	46.74	51.35	115.02	96.83	88.14	64.28	63.06	56	72.03	67.54	47.77	53.14	48.67	72.41	62.93	55.58	49.88	63.1	42.87	44.4	38.86	69.29	50.8	60.32	27.79	69.6	70.52
Net Profit	17.39	15.71	17.03	18.59	19.88	22.07	17.85	21.97	11.38	23.6	23.33	23.99	23.37	18.05	20.89	27.44	22.45	32.31	27.78	58.86	85.45	75.27	68.03	51.65	48.81	42.58	58.28	55.32	34.78	38.74	36.67	56.18	47.97	39.6	36.71	47.31	33.27	34.96	37.09	62.77	53.97	45.16	40.55	55.26	50.13
EPS	7.18	6.49	7.03	7.68	8.21	9.11	7.56	8.7	4.77	9.89	9.78	9.97	9.82	7.65	8.86	12.06	9.56	13.87	11.92	25.26	9.17	8.08	7.3	5.54	5.25	4.6	6.29	5.97	3.76	4.18	3.96	6.07	5.18	4.29	3.99	5.15	3.62	3.83	4.06	6.88	5.91	4.95	4.44	6.05	5.49

Cashflow

₹Cr

Metric (₹ crore)	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Operating Cash Flow	104.59	133.3	174.75	69.77	143.09	250.74	154.95	70.41	133.32	358.92	244.58	253.54
Investing Cash Flow	-107.01	-98.79	-106.98	-73.54	-61.67	-33.21	-71.78	-149.64	-163.97	-223.65	-164.63	-173.41
Financing Cash Flow	1.46	-33.26	-68.23	3.92	-80.07	-215.41	-81.13	92.03	16.54	-136.03	-82.12	-77.44
Net Cash Flow	-0.95	1.24	-0.46	0.15	1.35	2.12	2.04	12.8	-14.11	-0.76	-2.17	2.69

Balance Sheet

Annual

₹Cr

Metric (₹ crore)	FY15	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Equity / Shareholders' Funds	308.15	357.4	400.13	455.43	543.45	652.49	913.4	1,036.3	1,192.66	1,281.96	1,369.34	1,549.22
Total Liabilities	693.79	744.8	790.9	933.98	912.04	924.01	852.61	1,171.66	1,228.73	1,150.4	1,205.34	1,266.04
Total Assets	1,001.94	1,102.2	1,191.04	1,389.41	1,455.49	1,576.5	1,766.01	2,207.96	2,421.4	2,432.36	2,574.68	2,815.26

Shareholding

₹3.6K CrMarket Cap

Promoter & promoter group (54.43%)

DIIs (10.29%)

FIIs (1.52%)

Public & others (33.75%)